Biodesix, Inc. (BDSX)

Biodesix Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	30	18.99	26.25	26.28	43.09	32.71
Cash & Short-Term Investments	30	18.99	26.25	26.28	43.09	32.71
Cash Growth	44.71%	-27.66%	-0.15%	-39.00%	31.72%	-47.35%
Receivables	9.11	9.04	8.6	7.68	5.07	3.66
Inventory	1.2	1.3	1	1.4	1.4	2.9
Restricted Cash	0.1	0.1	0.1	0.1	0.1	0.1
Other Current Assets	3.16	3.1	3.54	4.22	3.68	4.25
Total Current Assets	43.57	32.52	39.48	39.68	53.33	43.61
Property, Plant & Equipment	29.65	30.81	31.8	29.61	8.82	4.18
Goodwill	15.03	15.03	15.03	15.03	15.03	15.03
Other Intangible Assets	2.98	3.88	5.87	7.91	9.8	11.62
Other Long-Term Assets	4.11	5.23	5.06	6.86	5.92	1.66
Total Assets	95.33	87.48	97.24	99.1	92.91	76.1

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	2.16	3.08	2.19	2.93	1.69	1.66
Accrued Expenses	10.41	11.03	10.06	7.71	8.22	7.67
Current Portion of Long-Term Debt	-	0.01	0.02	0.05	0.05	0.02
Current Portion of Leases	1.61	1.36	0.72	0.25	1.54	-
Current Unearned Revenue	0.21	0.96	0.68	0.32	0.96	1.85
Other Current Liabilities	0.91	0.99	0.64	22.15	10.38	17.76
Total Current Liabilities	15.29	17.44	14.32	33.42	22.84	28.96
Long-Term Debt	46.82	47.45	36.41	35.23	25	9.99
Long-Term Leases	23.37	24.04	24.83	25.16	5.25	-
Long-Term Unearned Revenue	0.1	0.1	0.2	0.3	0.4	0.8
Other Long-Term Liabilities	0.6	0.92	0.62	0.41	18.8	16.62
Total Liabilities	86.18	89.94	76.37	94.52	72.3	56.37

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.1	0.08	0.03
Additional Paid-In Capital	521.96	495.29	483.37	424.05	387.95	321.67
Retained Earnings	-512.83	-497.76	-462.5	-419.57	-367.42	-301.97
Total Common Equity	9.14	-2.47	20.88	4.58	20.61	19.73
Shareholders' Equity	9.14	-2.47	20.88	4.58	20.61	19.73
Total Liabilities & Equity	95.33	87.48	97.24	99.1	92.91	76.1

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	71.8	72.85	61.98	60.69	31.85	10.01
Net Cash (Debt)	-41.8	-53.87	-35.73	-34.41	11.24	22.7
Net Cash Growth	-	-	-	-	-50.49%	-33.93%
Net Cash Per Share	-4.71	-7.13	-5.52	-8.38	5.34	16.59
Filing Date Shares Outstanding	10.55	9.86	7.3	4.85	3.9	1.57
Total Common Shares Outstanding	10.55	8.25	7.27	4.81	3.88	1.54
Working Capital	28.27	15.08	25.17	6.27	30.5	14.65
Book Value Per Share	0.87	-0.30	2.87	0.95	5.31	12.81
Tangible Book Value	-8.87	-21.38	-0.03	-18.36	-4.22	-6.92
Tangible Book Value Per Share	-0.84	-2.59	-0.00	-3.82	-1.09	-4.50
Machinery	9.3	8.72	8.36	8.44	7.23	7.97
Construction In Progress	0	0.03	0.09	-	2.95	0.02
Leasehold Improvements	28.41	28.27	28.19	24.71	2.37	2.34

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Aug 5, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 3, 2026

Data Sources Report a data error